News Daily News Elevations in hs-cTnI Linked to Higher Risk of CVD, Particularly Heart Failure Michael O'Riordan May 06, 2019
News Daily News Mortality From Heart Failure Increasing in United States Michael O'Riordan May 06, 2019
News Daily News No Need for Niacin? Meta-analysis Argues the End Is Nigh Yael L. Maxwell April 22, 2019
News Conference News ACC 2019 REDUCE-IT Subanalysis: Icosapent Ethyl Reduces Total and Recurrent CV Events Yael L. Maxwell March 22, 2019
News Conference News ACC 2019 Modest LDL Cholesterol Reduction With Bempedoic Acid in Among High-Risk Patients: CLEAR Wisdom Michael O'Riordan March 20, 2019
News Daily News Rising Number of CV-Related Maternal Deaths Spurs Need for #CardioObstetrics Caitlin E. Cox February 27, 2019
News Daily News New Equations Help ID Patients at Low Risk for Bleeding With Aspirin Michael O'Riordan February 26, 2019
News Daily News Lower Statin Adherence Linked to Higher Mortality Risk, Even Among Patients With Established ASCVD Lucy Hicks February 15, 2019
News Daily News Intensive BP Lowering May Have Cognitive Benefits: SPRINT MIND Todd Neale February 04, 2019
News Daily News Most Cardiovascular Drugs Can Be Safely Used in Pregnancy, Review Suggests Todd Neale February 01, 2019
News Conference News WCC 2018 CVD, Other Noncommunicable Diseases Hit Lower-Income Countries With Heavy Financial Burden Todd Neale December 06, 2018
News Daily News Benefits of Statins Only Exceed Harms at Higher 10-Year Risk Thresholds, Study Suggests Michael O'Riordan December 03, 2018
News Daily News Certain Risk Factors Carry Higher MI Risk in Women Than in Men Shelley Wood November 23, 2018
News Conference News AHA 2018 EMPA-HEART Offers Mechanistic Clues for Empagliflozin’s Cardiac Benefits Michael O'Riordan November 16, 2018
News Opinion Conversations in Cardiology Conversations in Cardiology: Can a Patient With Tissue Valves Switch From Warfarin to a NOAC? November 16, 2018
News Conference News AHA 2018 Alirocumab Should Be Priced at $6,300 Annually: ODYSSEY Cost-Effectiveness Study Michael O'Riordan November 15, 2018
News Conference News AHA 2018 Methotrexate, an Anti-inflammatory, Fails to Lower Risk of Cardiovascular Events: CIRT Michael O'Riordan November 10, 2018
News Conference News AHA 2018 REDUCE-IT: Prescription Fish Oil Prevents CV Events in Patients With High Triglycerides Todd Neale November 10, 2018
News Conference News AHA 2018 VITAL: No Benefits to Vitamin D and Omega-3s in Reducing Major CV Events, Cancer Shelley Wood November 10, 2018
News Daily News ODYSSEY Outcomes Published as New Cholesterol Guidelines Loom Michael O'Riordan November 07, 2018